General Information
Revision date
2019-02-01
Product name
Nalidixic acid sodium salt
Substance name
Nalidixic acid sodium salt
Product Synonyms
Sodium 1-ethyl-1,4-dihydro-7-methyl-4-oxo-1,8-naphthyridine-3-carboxylate
CAS No.
3374-05-8
supplier name
Scafell Organics
Emergency telephone
+44 (0) 7590 545705
Icons in SDS
Company Information
company name
Molekula Ltd
e-mail address of the competent person responsible for the Safety Data Sheet
info@molekula.com, kbowen@molekula.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H302, H317, H334
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
CLP CLASSIFICATION
Acute toxicity (oral), Category 4 H302 Respiratory sensitisation, Category 1 H334 Skin sensitisation, Category 1 H317
Hazard statements
see section 16 : H302 - Harmful if swallowed. H317 - May cause an allergic skin reaction. H334 - May cause allergy or asthma symptoms or breathing difficulties if inhaled.
Adverse physicochemical, human health and environmental effects
No additional information available
2.2 Label elements
Labelling according to Regulation (EC) No. 1272/2008 [CLP]Extra labelling to displayExtra classification(s) to display
Hazard pictograms
GHS07 GHS08
Signal word
Danger
Precautionary statements
P261 - Avoid breathing dust/fume/gas/mist/vapours/spray. P270 - Do not eat, drink or smoke when using this product. P280 - Wear protective gloves/protective clothing/eye protection/face protection. P301+P310 - IF SWALLOWED: Immediately call a POISON CENTER or doctor. P304+P340 - IF INHALED: Remove person to fresh air and keep comfortable for breathing. P333+P313 - If skin irritation or rash occurs: Get medical advice/attention.
2.3 Other hazards
This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII
